Le-blen Fgf Serum
Product Images NDC 72271-101

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Le-blen Fgf Serum (NDC 72271-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Leblen Beauty Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

6aa0c6cd 7155 1413 E053 2991aa0aa359

Drug Facts panel for Le-Blen FGF Serum by LeBlen Beauty Inc. It lists active ingredients glycerin 25%, SH-polypeptide-11 0.95%, and sodium hyaluronate 0.7% as skin protectants. The panel includes uses, warnings, directions for application, other storage information, inactive ingredients, and distributor information.*

FDA Label Image

Le-blen Fgf Serum (Fgf Serum Dfp)

This Drug Facts panel from Le-Blen FGF Serum lists active ingredients including glycerin, SH-polypeptide-11, and sodium hyaluronate as skin protectants. It provides usage instructions for skin care after laser treatments, warnings for external use, and directions to apply 2-3 drops after cleansing. Other information notes avoiding direct sunlight exposure. Inactive ingredients and distributor details for Le-Blen Beauty Inc. are included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.